Concepedia

Rituximab plus Short-Duration Chemotherapy Followed by Yttrium-90 Ibritumomab Tiuxetan as First-Line Treatment for Patients with Follicular Non-Hodgkin Lymphoma: A Phase II Trial of the Sarah Cannon Oncology Research Consortium

John D. Hainsworth, David R. Spigel, Tiffanie Markus, Dianna Shipley, Dana S. Thompson, Richard Rotman, C. Dannaher, F. Anthony Greco

Clinical Lymphoma & Myeloma · 2009 · 60 citations · 18 references

DOI

Concepts

References

18

Nonparametric Estimation from Incomplete Observations

Edward L. Kaplan, Paul Meier · Journal of the American Statistical Association · 1958 · 39.1K citations

, , +10

Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group

W. Hiddemann · Blood · 2005 · 1.3K citations · Full text

, , +7

CVP chemotherapy plus rituximab compared with CVP as first-line treatment for advanced follicular lymphoma

R. E. Marcus · Blood · 2004 · 970 citations · Full text

, , +5

<sup>131</sup>I-Tositumomab Therapy as Initial Treatment for Follicular Lymphoma

Mark Kaminski, Melissa Tuck, Judith Estes et al. · New England Journal of Medicine · 2005 · 715 citations · Full text

, , +15

Treatment With Ibritumomab Tiuxetan Radioimmunotherapy in Patients With Rituximab-Refractory Follicular Non-Hodgkin’s Lymphoma

Thomas E. Witzig, Ian W. Flinn, Leo I. Gordon et al. · Journal of Clinical Oncology · 2002 · 650 citations

, , +14